Avidity Biosciences Inc. (RNA)
NASDAQ: RNA
· Real-Time Price · USD
29.34
-0.46 (-1.54%)
At close: Jun 17, 2025, 3:59 PM
30.10
2.59%
After-hours: Jun 17, 2025, 07:58 PM EDT
-1.54% (1D)
| Bid | 25 |
| Market Cap | 3.54B |
| Revenue (ttm) | 8.93M |
| Net Income (ttm) | -369.22M |
| EPS (ttm) | -3 |
| PE Ratio (ttm) | -9.78 |
| Forward PE | -6.75 |
| Analyst | Buy |
| Ask | 37.78 |
| Volume | 1,488,091 |
| Avg. Volume (20D) | 1,569,346 |
| Open | 30.24 |
| Previous Close | 29.80 |
| Day's Range | 29.27 - 31.14 |
| 52-Week Range | 21.51 - 56.00 |
| Beta | 0.95 |
Analyst Forecast
According to 0 analyst ratings, the average rating for RNA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-18.65%
Shares of vaccine and gene therapy stocks are trad...
Unlock content with
Pro Subscription
3 months ago
+10.24%
Avidity Biosciences shares are trading higher after BMO Capital initiated coverage on the stock with an Outperform rating and anounced a $72 price target.
